Publicacions en col·laboració amb investigadors/es de Universidad Pablo de Olavide (15)

2023

  1. A Cluster Randomized Controlled Trial of the Archena Infancia Saludable Project on 24-h Movement Behaviors and Adherence to the Mediterranean Diet among Schoolchildren: A Pilot Study Protocol

    Children, Vol. 10, Núm. 4

  2. Burden of infectious disease studies in Europe and the United Kingdom: a review of methodological design choices

    Epidemiology and Infection

  3. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

  4. Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses

    Frontiers in Cell and Developmental Biology, Vol. 11

2021

  1. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

  2. Erratum: Gaia Early Data Release 3: Summary of the contents and survey properties (Astronomy and Astrophysics DOI: 10.1051/0004-6361/202039657)

    Astronomy and Astrophysics

  3. Gaia Early Data Release 3: Acceleration of the Solar System from Gaia astrometry

    Astronomy and Astrophysics, Vol. 649

  4. Gaia Early Data Release 3: Structure and properties of the Magellanic Clouds

    Astronomy and Astrophysics, Vol. 649

  5. Gaia Early Data Release 3: Summary of the contents and survey properties

    Astronomy and Astrophysics, Vol. 649

  6. Gaia Early Data Release 3: The Gaia Catalogue of Nearby Stars

    Astronomy and Astrophysics, Vol. 649

  7. Gaia Early Data Release 3: The Galactic anticentre

    Astronomy and Astrophysics, Vol. 649

  8. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

2019

  1. Cardiotrophin-1 is an anti-inflammatory cytokine and promotes IL-4–induced M2 macrophage polarization

    FASEB Journal, Vol. 33, Núm. 6, pp. 7578-7587

  2. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN